Back to news

Silexion Therapeutics Corp Ord Stock Short Interest Rises to 91.58%

Investivoq ShortTracker

Silexion Therapeutics Corp Ord short interest was 91.58% of the float on September 30th, according to new data we received from Benzinga. Short interest totaled 4,925,958 shares, which was an increase of 1,964.38% from September 15th.

It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.

EARLY ACCESS
Receive SLXN Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

Silexion Therapeutics Corp Ord Hedge Fund Activity

We have seen 4 institutional investors add shares of Silexion Therapeutics Corp Ord stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • HRT FINANCIAL LP added 15,239 shares (+inf%) to their portfolio in Q2 2026, for an estimated $38,859
  • TWO SIGMA SECURITIES, LLC removed 11,657 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,725
  • UBS GROUP AG added 894 shares (+172.9%) to their portfolio in Q2 2026, for an estimated $2,279
  • MONTAG A & ASSOCIATES INC added 300 shares (+inf%) to their portfolio in Q2 2026, for an estimated $765
  • PFLUG KOORY, LLC removed 300 shares (-90.1%) from their portfolio in Q2 2026, for an estimated $765
  • ROYAL BANK OF CANADA added 76 shares (+inf%) to their portfolio in Q2 2026, for an estimated $193
  • SBI SECURITIES CO., LTD. removed 18 shares (-90.0%) from their portfolio in Q2 2026, for an estimated $45

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Investivoq API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.